BioVid President Peggy Hirtle has been named an MM+M (Medical Marketing + Media) Women of Distinction Honoree for 2024. Now in their ninth year, the MM+M Women of Distinction and Women to Watch programs celebrate healthcare marketing executives who have significantly impacted their organizations — and the industry writ large — during the past year.

Peggy Hirtle is a pioneer in pharmaceutical brand building. Her groundbreaking work is truly inspiring. She champions the power of deep human understanding, weaving social science-based insights with world-class strategic thinking to build pharmaceutical brands that resonate with patients and physicians alike. Her disruptive application of cognitive insight and cognitive marketing to brand building has set her apart in the industry, allowing her to help brands connect with audiences on profound levels.

Peggy has not only achieved remarkable success for her clients but also uplifted her colleagues and the organizations that have employed her. Her dedication to excellence has positively impacted millions of lives worldwide.

Catrina Salama, one of Peggy’s mentees, was recently recognized as an honoree for Greenbook’s Future List 2024. Catrina shares the following: “Peggy is someone I have admired from the start of my BioVid journey. Her mentorship provides me the opportunity to follow in the footsteps of a collaborative, solution-oriented, and focused visionary in our field. Our sessions are an incredible opportunity for me to not only learn how Peggy has gotten to the place she has, but to also see her roll up her sleeves, giving me a glimpse of the process behind the brilliance.”

The 2024 Women of Distinction and Women to Watch honorees will be celebrated at an in-person event on June 13 in New York City and profiled in the May print edition of MM+M.